Two Years, Nine Doubles … and Our Eighth Takeover

Email

The reported buyout of Astex Pharmaceuticals Inc. (Nasdaq: ASTX) that we told you about in yesterday's Private Briefing was confirmed - making this the eighth recommendation to result in a buyout or merger since we launched this service just two years ago.

It's also our ninth recommendation to double, triple or quadruple during that same two-year time frame.

To continue reading, please click here...

Leave a Reply

Your email address will not be published. Required fields are marked *


+ 4 = ten

Some HTML is OK

© 2014 Money Map Press. All Rights Reserved. Protected by copyright of the United States and international treaties. Any reproduction, copying, or redistribution (electronic or otherwise, including the world wide web), of content from this webpage, in whole or in part, is strictly prohibited without the express written permission of Money Morning. 16 W. Madison St. Baltimore, MD, 21201, Email: customerservice@MoneyMorning.com